Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Biomarkers of Aging Consortium Announces Winners of Prestigious Biomarkers of Aging Challenge


News provided by

Biomarkers of Aging Consortium

Nov 15, 2024, 12:00 ET

Share this article

Share toX

Share this article

Share toX

2024 Biomarkers of Aging Conference at Harvard
2024 Biomarkers of Aging Conference at Harvard

The Biomarkers of Aging Consortium has announced the winners of the 2024 Biomarkers of Aging Challenge Series, recognizing significant advances in predicting biological age and mortality risk through innovative data modeling.

BOSTON, Nov. 15, 2024 /PRNewswire-PRWeb/ -- The Biomarkers of Aging Consortium is proud to announce the winners of Phase 2 of the 2024 Biomarkers of Aging Challenge Series.

Participants of this challenge phase were tasked with developing a best-in-class proteomic predictor of mortality. Mortality is one of the most commonly studied outcomes for biomarkers of aging, owing to its binary and clearly defined nature. Both first generation biomarkers of aging as well as newer models trained specifically to predict time to death have been shown to be able to predict mortality, and the latter have yielded some of the best predictors of mortality and age-related disease available to date.

The 2024 Biomarkers of Aging Challenge Series has propelled aging research forward, with winning teams developing groundbreaking proteomic and epigenetic predictive models that promise to transform our understanding and assessment of biological aging.

Post this

After months of rigorous analysis, groundbreaking research, and innovative data modeling, the top honors for Phase 2 and $40,000 have been awarded to Team Kauai, comprised of members Jakob Träuble (University of Cambridge), Korbinian Träuble (Helmholtz Munich), and Raphael Lermer (German Heart Center Munich), for their proteomic predictive model of mortality, which outperformed the epigenetic clock GrimAgeV2.

These Phase 2 winners join the winners of Phase 1 of the Challenge, which was focused on prediction of chronological age using epigenetics, and showcased remarkable predictive accuracy, achieving an average error of less than 3 years.

  • 1st Place: Julian Reinhard, also known as "DarthVenter," Machine Learning Scientist at Evotec, achieved a final score of 2.45 years age error. Julian received $15,000 USD in awards.
  • 2nd Place: Lucas Paulo de Lima Camillo, Head of Machine Learning at Shift Bioscience, achieved a final score of 2.55 years age error. Lucas received $10,000 USD in awards.
  • 3rd Place: Team "ZetaPartition", comprising academics Jakob Träuble and Stefan Jokiel, achieved a final score of 2.46 years age error. The team received $5,000 USD in awards.

The Challenge Series was designed to push the boundaries of aging research by engaging experts in omics profiling and advanced data modeling to develop reliable biomarkers of biological age. The competition leveraged a unique dataset, featuring comprehensive proteomic profiles—including Alamar Biosciences's high-sensitivity NULISAseq™ immunoassay panels—alongside DNA methylation data and longitudinal health outcomes from over 500 individuals. This data enabled participants to create predictive models of chronological age, mortality risk, and will next utilize an expanded multi-omic dataset to enable researchers to predict future disease incidence.

Dr. Mahdi Moqri of the Biomarkers of Aging Consortium remarked, "The contributions of Jakob, Korbinian, and Raphael reflect exactly the kind of pioneering thinking we aimed to foster with this challenge. Their approaches have set a new standard for innovation in aging biomarker research, providing potential tools for improved longevity assessments."

Dr. Yuling Luo, Founder, Chairman & CEO of Alamar Biosciences, added, "We are thrilled to celebrate the exceptional work of these talented scientists. Their achievements underscore the power of collaborative innovation and the potential impact of precision proteomics in transforming longevity research."

The winners were recently recognized at a dedicated ceremony during the 2024 Biomarkers of Aging Conference at Harvard Medical School, Boston, MA on November 2, 2024. This celebration marked the culmination of Phase II of the Challenge and sets the stage for Phase III, focused on health span prediction and the modeling of multi-morbidity outcomes, beginning in Q3 2025.

For more information about the Biomarkers of Aging Challenge Series and future participation opportunities, please visit www.agingconsortium.org.

About the Biomarkers of Aging Consortium

Established in 2022, the Biomarkers of Aging Consortium brings together leading researchers and industry experts to develop, validate, and apply biomarkers for aging and longevity. The Consortium fosters collaboration to accelerate advancements in the field. For more details, visit www.agingconsortium.org.

Media Contact

Dane Gobel, Biomarkers of Aging Consortium, 1 2066139364, [email protected], agingconsortium.org 

SOURCE Biomarkers of Aging Consortium

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.